Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

145.99 -1.45 (-0.98%)
Streaming Delayed Price Updated: 1:47 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
How Is The Market Feeling About Masimo?
 
Via Benzinga
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
1 Small-Cap Stock Worth Your Attention and 2 Facing Challenges
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Consumer Tech News (August 18–August 22): Powell Turns Dovish As Walmart, Target Earnings Steer Sentiment, While AI Hangover Hits Palantir
Powell's dovish Jackson Hole tone, mixed WMT/TGT/TJX earnings, and an AI hangover led by PLTR's slide gave way to a late-week risk rally. 
Via Benzinga
Topics Artificial Intelligence
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature
Via Stocktwits
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Sallie Mae, Two Harbors Investment, Flowserve, Masimo, and Select Medical Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights
Apple reintroduced blood-oxygen tracking on its watches after a Customs ruling, but Masimo has sued to block the feature again. 
Via Benzinga
Topics Intellectual Property Lawsuit
3 Unprofitable Stocks That Fall Short
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
Is the Market Bullish or Bearish on Masimo?
 
Via Benzinga
How Do Investors Really Feel About Masimo?
 
Via Benzinga
Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today
 
Via Benzinga
Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling
Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a favorable customs ruling. 
Via Benzinga
Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
MASI Q2 Deep Dive: Margin Expansion Amid Tariff Pressures and Strategic Leadership Changes
Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s... 
Via StockStory
Topics World Trade
Is the Market Bullish or Bearish on Masimo?
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Q2 Earnings Highlights: Masimo (NASDAQ:MASI) Vs The Rest Of The Patient Monitoring Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q2, starting with Masimo... 
Via StockStory
Topics Artificial Intelligence
Masimo’s (NASDAQ:MASI) Q2: Beats On Revenue But Stock Drops
Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s... 
Via StockStory
Topics World Trade
Masimo (MASI) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Tuesday afternoon. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
1 Healthcare Stock to Consider Right Now and 2 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years
 
Via Benzinga
Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years
 
Via Benzinga
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Masimo (NASDAQ:MASI) and the... 
Via StockStory
Topics Artificial Intelligence
MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds
Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.5% year on year to $372 million. The company expects the full year’s... 
Via StockStory
Topics World Trade
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Masimo’s (NASDAQ:MASI) Q1: Beats On Revenue But Stock Drops
Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 24.5% year on year to $372 million. The company expects the full... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.